Companies · Nuclear, fuel and SMR · data
newcleo Ltd
Profile
newcleo, founded in 2021 and headquartered in London with engineering in France and Italy, develops lead-cooled fast reactors fuelled with MOX: a 30 MWe LFR-AS-30 demonstrator followed by the 200 MWe LFR-AS-200. Its safety options dossier was submitted to the French regulator ASNR (reported 15 Jan 2026), with construction authorisation applications for the reactor and a MOX pilot fuel line planned before end-2027 and operation targeted for 2032; WNN also flagged a scaling-back of UK operations. Private (venture-funded); no market data apply.
Source: the SMR projects dataset (WNN 15 Jan 2026), 9 Oct 2026 · confidence mediumKey projects
| Project | Country | Stage | Note | Map |
|---|---|---|---|---|
| newcleo LFR-AS-30 demonstrator / LFR-AS-200 | FRA | Pre-licensing | Regulator stage as of 9 Oct 2026: Safety options dossier submitted to ASNR (reported 15 Jan 2026); construction authorisation applications for reactor and MOX fuel line planned before end-2027; public debate 2026 | open on the map |
Deals
No deal recorded for this company (as of 9 Oct 2026). All deals.
Documents
| Document | Type | Date |
|---|---|---|
| WNN: Licensing of newcleo's SMR progresses in France | News | 15 Jan 2026 |
Chart
TradingView symbol: n/a · private, unlisted
- Market cap, USD
- n/a · private, unlisted
- Market cap, local
- n/a · private, unlisted